AstraZeneca Wins U-Turn On Diabetes Drug�, Meet Them At Diabetes 2013, 1-2 October, London, United Kingdom

In final draft guidance published in recent weeks, NICE has recommended dapagliflozin (Forxiga, Bristol-Myers Squibb and Astra Zeneca) for some people with type 2 diabetes. ��The agency changed its position on the drug after requesting further information from its manufacturers. NICE said it expected to publish final guidance on Forxiga in June 2013 "We are pleased to recommend dapagliflozin for some people with type 2 diabetes. It is a serious problem in the UK and dapagliflozin provides another treatment option for some people with this condition...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Conferences Source Type: news